Table 3.
Comparison of diabetes-specific physiological outcome measures in type 1 diabetes control patients and diabetes patients submitted to total pancreatectomy (TP)
| Complication/outcome | Cohort | P-value | |
|---|---|---|---|
| Control group | TP group | ||
| (n = 23) | (n = 23) | ||
| Hypoglycaemic attack in the past month, n | 12 | 14 | 0.754 |
| Hypoglycaemia requiring hospital admission in past year, n | 0 | 5 | 0.5 |
| Previous episode of diabetic ketoacidosis, n | 2 | 0 | 0.5 |
| Peripheral vascular disease, n | 0 | 1 | 1 |
| Cardiovascular disease, n | 12 | 9 | 0.508 |
| Peripheral neuropathy, n | 3 | 5 | 0.727 |
| Autonomic neuropathy, n | 1 | 0 | 1 |
| Erectile dysfunction, n | 0 | 0 | 1 |
| Retinopathy, n | 5 | 3 | 0.688 |
| Nephropathy, n | 1 | 1 | 1 |
| Injection site complications, n | 0 | 0 | 1 |
| Has/under consideration for an insulin pump, n | 2 | 0 | 0.5 |
| HbA1c mmol/mol, median (IQR) | 74.5 (58.75–91) | 65 (56.25–80) | 0.299a |
McNemar's chi-squared test or
a
Wilcoxon signed rank test.
IQR, interquartile range.